Loading company…
Riskpilot
← Back to search
Sign in
Get full access
CaDo Biotechnology IvS
IVS
Dissolved
CVR 38777815
Kajerødvej 15
Forskning og eksperimentel udvikling indenfor bioteknologi · NACE 721100
Est. 2017
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2019
DKK 21K
-205% vs 2018
EBITDA margin
100.0%
+204% vs 2018
Equity ratio
91.0%
Financial strength
Net profit 2019
DKK 20K
+199% vs 2018
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2018
0M
0%
2019
Key figures
Annual report 2019
Revenue
DKK 21K
-205%
EBITDA
DKK 21K
+204%
Net profit
DKK 20K
+199%
Total assets
DKK 33K
+91%
Equity
DKK 30K
+204%
Employees
—
—
Company information
Legal name
CaDo Biotechnology IvS
CVR number
38777815
Legal form
Iværksætterselskab
NACE code
721100 · Forskning og eksperimentel udvikling indenfor bioteknologi
Founded
1. juli 2017
Share capital
DKK 20.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene, eller af hele direktionen i forening.
Contact
Address
Kajerødvej 15
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Forskning og eksperimentel udvikling indenfor bioteknologi
Companies in Rudersdal
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
Income statement
DKK thousands
Item
2018
2019
Revenue
-20
21
Staff expenses
-0
-0
EBITDA
-20
21
Depreciation & amort.
-0
-0
EBIT
-20
21
Net financials
0
0
Profit before tax
-20
21
Tax
-0
1
Net profit
-20
20
Balance sheet
DKK thousands
Item
2018
2019
Total assets
17
33
Equity
10
30
Long-term debt
0
0
Short-term debt
7
3
Total debt
7
3
Financial ratios
5-year trend
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
2018
2019
Equity ratio
91.0%
This company
38.2%
Market median
+138% vs market
2018
2019
Return on equity
67.1%
This company
18.4%
Market median
+265% vs market
2018
2019
Net profit margin
94.6%
This company
8.1%
Market median
+1068% vs market
2018
2019
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
2018
2019
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
2018
2019
Annual reports & filings
Annual report 2019
Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via CVR / Virk · Period 2017-07-01 – 2018-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (1)
AL
Anne-Marie Lund Winther
Chief Executive Officer
Chief Executive Officer
2017 – 2020
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
AM WINTHER HOLDING ApS
Company
50–66.65%
50–66.65%
2018
William Brown
Individual
50–66.65%
50–66.65%
2017
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of CaDo Biotechnology IvS also hold positions in
0
other companies.
Person
Role here
Other companies
Anne-Marie Lund Winther
Chief Executive Officer
0 companies